vimarsana.com

Latest Breaking News On - Rafael pharmaceuticals inc - Page 11 : vimarsana.com

ALERT: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, HFC, MNR; Shareholders are Encouraged to Contact the Firm

ALERT: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, HFC, MNR; Shareholders are Encouraged to Contact the Firm
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

SHAREHOLDER ALERT: Rigrodsky Law, P A Reminds Investors of Investigation of RIVE, IACB, BCYP,

SHAREHOLDER ALERT: Rigrodsky Law, P A Reminds Investors of Investigation of RIVE, IACB, BCYP,
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RBNC, GPX, RFL, IKNX; Shareholders are Encouraged to Contact the Firm

IKONICS Corporation (NASDAQ: IKNX)  concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to TeraWulf Inc. Under the terms of the agreement, each outstanding share of IKONICS common stock will receive $5.00 in cash, one Contingent Value Right, and one share of the combined company s common stock.  If you are an IKONICS shareholder, . Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.